BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36314929)

  • 21. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
    Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
    Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia].
    Qin T; Xu Z; Zhang Y; Lin Y; Ru K; Fang L; Zhang H; Pan L; Hu N; Qu S; Wang J; Xing R; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):94-9. PubMed ID: 27014976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A long-term follow-up study of 82 children with acute myeloid leukemia].
    Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML.
    Shi L; Chen S; Lu Y; Wang X; Xu L; Zhang F; Yang L; Wu X; Li B; Li Y
    Cancer Cell Int; 2013 Apr; 13(1):37. PubMed ID: 23627638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
    Ciftciler R; Demiroglu H; Haznedaroglu IC; Sayınalp N; Aksu S; Ozcebe O; Goker H; Aydın MS; Buyukasık Y
    Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):729-734. PubMed ID: 31540855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of MiR-34a/b/c Expression with Treatment Response and Prognosis of Elderly Patients with Acute Myeloid Leukemia].
    Li H; Bao HX; Qin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):476-483. PubMed ID: 32319382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CD19 and specific KIT-D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities.
    Wang B; Yang B; Ling Y; Zhang J; Hua X; Gu W; Yan F
    Cancer Med; 2021 Feb; 10(3):1091-1102. PubMed ID: 33382538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
    Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
    [No Abstract]   [Full Text] [Related]  

  • 30. Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
    Hasegawa D; Tawa A; Tomizawa D; Watanabe T; Saito AM; Kudo K; Taga T; Iwamoto S; Shimada A; Terui K; Moritake H; Kinoshita A; Takahashi H; Nakayama H; Koh K; Goto H; Kosaka Y; Miyachi H; Horibe K; Nakahata T; Adachi S
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28692. PubMed ID: 32886449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IER3 (IEX-1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients.
    Ke S; Zhang X; Xiang X; Lu Y; An H
    Int J Lab Hematol; 2022 Apr; 44(2):342-348. PubMed ID: 34729939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety and depression predict unfavorable survival in acute myeloid leukemia patients.
    Ding T; Wang X; Fu A; Xu L; Lin J
    Medicine (Baltimore); 2019 Oct; 98(43):e17314. PubMed ID: 31651837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia.
    Chen T; Chen F
    Hematology; 2021 Dec; 26(1):1018-1024. PubMed ID: 34871521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
    Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Impact of Induction Treatment Response on the Prognosis of Pediatric Core Binding Factor-Acute Myeloid Leukemia Patients].
    Zeng HM; Hu GH; Lu AD; Jia YP; Zuo YX; Wu J; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):56-61. PubMed ID: 33554797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia.
    Huang J; Zhao H; Hong M; Zhu H; Zhu Y; Lian Y; Li S; Li J; Qian S
    BMC Cancer; 2018 Dec; 18(1):1269. PubMed ID: 30567513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical Analysis of Pediatric Acute Myeloid Leukemia with CCLG-AML 2015 Regimen].
    Wang P; Xiong H; Li JX; Wang Z; Yang L; Tao F; Chen Z; DU Y; Zhang AP; Luo LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):373-380. PubMed ID: 35395966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study.
    Bao Y; Zhao J; Li ZZ
    Clin Transl Oncol; 2018 Jul; 20(7):870-880. PubMed ID: 29181696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-181b-5p insufficiency predicts treatment response failure risk and unfavorable event-free survival as well as overall survival in acute myeloid leukemia patients.
    Lu H; Ding Y; Dong Y; Luo X; Wang X; Xiu B; Liang A; Zhang W
    Oncol Lett; 2022 Oct; 24(4):330. PubMed ID: 36039054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Clinical Characteristics and Prognosis of Patients with Acute Myeloid Leukemia Combine Paroxysmal Nocturnal Hemoglobinuria].
    Wen J; Wang H; Xie J; Li G; Li ZZ; Zhang XB; Shi R; Song YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1080-1084. PubMed ID: 34362485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.